1029720-23-7 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 3-(dibromomethyl)picolinate is used as a building block for the synthesis of new drugs. Its chemical structure allows for the creation of a wide range of pharmaceutical compounds, making it a valuable intermediate in drug development.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 3-(dibromomethyl)picolinate is utilized as a component in the production of crop protection products. Its properties contribute to the effectiveness of these products, enhancing their ability to protect crops from pests and diseases.
Used in Biochemical Research:
Methyl 3-(dibromomethyl)picolinate is employed as a research tool in the study of biochemical processes. Its unique structure provides insights into various biological mechanisms, aiding in the advancement of scientific understanding in this field.
Check Digit Verification of cas no
The CAS Registry Mumber 1029720-23-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,9,7,2 and 0 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1029720-23:
(9*1)+(8*0)+(7*2)+(6*9)+(5*7)+(4*2)+(3*0)+(2*2)+(1*3)=127
127 % 10 = 7
So 1029720-23-7 is a valid CAS Registry Number.
1029720-23-7Relevant academic research and scientific papers
Tetrahydropyrido[d]pyridazinones - Promising scaffolds for drug discovery
Yaremenko, Anatoliy G.,Volochnyuk, Dmitriy M.,Shelyakin, Vyacheslav V.,Grygorenko, Oleksandr O.
, p. 6799 - 6803 (2013/07/26)
An approach to the synthesis of all possible tetrahydropyrido[d] pyridazinones has been developed. The method relies on the catalytic hydrogenation of the corresponding aromatic counterparts, which were obtained by cyclization of the relevant dibromomethyl-substituted pyridinecarboxylates with hydrazine. The synthetic schemes include 4-5 steps starting from commercially available materials. The tetrahydropyrido[d]pyridazinone scaffolds are combinations of a saturated heterocycle (piperidine) and a privileged aromatic heterocycle (pyridazinone); hence they are promising starting points for the design in medicinal chemistry.
